Debt to EBITDA ratio Analysis of Acasti Pharma Inc - Deep Dive
WARN : Please note that some of the values may not be in base currency

Debt to EBITDA of ACST
Mar-23
-0.0041
Very Poor Debt to EBITDA
Mar-22
-0.0052
Very Poor Debt to EBITDA
Growth
20.46
%
Debt to EBITDA Analysis of Acasti Pharma Inc
Debt to EBITDA Ratio of ACST rose handsomely by 20.46 % this year.
Debt to EBITDA Ratio with value of -0.0035 was highest in Year Mar-20 in last Five Years.
Debt to EBITDA Ratio with value of -0.0439 was lowest in Year Mar-19 in last Five Years.
Latest Debt to EBITDA Ratio with value of -0.0041 is Greater than Average Debt to EBITDA of -0.0131 in last five years.
Other Debt to EBITDA Related Info of ACST that may interest you.
Acasti Pharma Inc Overview
CodePricePrevious PricePrice ChangeSector
ACST2.692.7599 2.53 % Biotechnology
Fundamental AnalysisTechnical Analysis
Defination of Debt to EBITDA
The Debt to EBITDA Ratio is a solvency metric that measures the company's ability to meet its debt obligations by earnings before covering its interest, taxes, depreciation, and amortization.    more ..
Debt to EBITDA Formula
Debt to EBITDA Related Ratios
CashFlowFromOperationToDebtDebtToCapitalEVToEBITDA
Tsr Stability Index
No Significant Stability
FY - Historical Debt to EBITDA of Acasti Pharma Inc
PeriodMar-23Mar-22Mar-21Mar-20Mar-19Mar-18Mar-17
Debt to EBITDA-0.0041-0.0052-0.0086-0.0035-0.0439-0.089-0.123
Change20.46 %39.81 %-148.27 %92.07 %50.72 %27.70 %-6497017688.93 %
You are view first 7 Records. Log in to view all 14 in Premium view
FY Chart of Debt to EBITDA of Acasti Pharma Inc


Note : All Data Generated at the End of Trading Hours (EOD Data)